Literature DB >> 17139691

A 25-year review of sequential methodology in clinical studies.

Susan Todd1.   

Abstract

This paper explores the theoretical developments and subsequent uptake of sequential methodology in clinical studies in the 25 years since Statistics in Medicine was launched. The review examines the contributions which have been made to all four phases into which clinical trials are traditionally classified and highlights major statistical advancements, together with assessing application of the techniques. The vast majority of work has been in the setting of phase III clinical trials and so emphasis will be placed here. Finally, comments are given indicating how the subject area may develop in the future. Copyright (c) 2006 John Wiley & Sons, Ltd.

Mesh:

Year:  2007        PMID: 17139691     DOI: 10.1002/sim.2763

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  10 in total

Review 1.  Recent developments in clinical trial designs for HIV vaccine research.

Authors:  Laura Richert; Edouard Lhomme; Catherine Fagard; Yves Lévy; Geneviève Chêne; Rodolphe Thiébaut
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.

Authors:  André R Brunoni; Laura Tadini; Felipe Fregni
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

3.  A two-stage phase II clinical trial design with nested criteria for early stopping and efficacy.

Authors:  Michelle DeVeaux; Michael Kane; Wei Wei; Daniel Zelterman
Journal:  Pharm Stat       Date:  2019-09-10       Impact factor: 1.894

Review 4.  A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines.

Authors:  Pankaj Mistry; Janet A Dunn; Andrea Marshall
Journal:  BMC Med Res Methodol       Date:  2017-07-18       Impact factor: 4.615

Review 5.  The world is waiting, use sequential analysis and get us the evidence-based treatment we need for COVID-19.

Authors:  Adel El Taguri; Aisha Nasef
Journal:  Libyan J Med       Date:  2020-12       Impact factor: 1.657

6.  Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country.

Authors:  Geert Molenberghs; Marc Buyse; Steven Abrams; Niel Hens; Philippe Beutels; Christel Faes; Geert Verbeke; Pierre Van Damme; Herman Goossens; Thomas Neyens; Sereina Herzog; Heidi Theeten; Koen Pepermans; Ariel Alonso Abad; Ingrid Van Keilegom; Niko Speybroeck; Catherine Legrand; Stefanie De Buyser; Frank Hulstaert
Journal:  Contemp Clin Trials       Date:  2020-10-22       Impact factor: 2.226

7.  Pitfalls in the design and analysis of paediatric clinical trials: a case of a 'failed' multi-centre study, and potential solutions.

Authors:  Johanna H van der Lee; Michael W T Tanck; Judit Wesseling; Martin Offringa
Journal:  Acta Paediatr       Date:  2008-09-24       Impact factor: 2.299

8.  Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials.

Authors:  Munyaradzi Dimairo; Steven A Julious; Susan Todd; Jonathan P Nicholl; Jonathan Boote
Journal:  Trials       Date:  2015-12-23       Impact factor: 2.279

Review 9.  An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review.

Authors:  Abigail Stevely; Munyaradzi Dimairo; Susan Todd; Steven A Julious; Jonathan Nicholl; Daniel Hind; Cindy L Cooper
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

10.  Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency.

Authors:  Olivier Collignon; Franz Koenig; Armin Koch; Robert James Hemmings; Frank Pétavy; Agnès Saint-Raymond; Marisa Papaluca-Amati; Martin Posch
Journal:  Trials       Date:  2018-11-20       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.